International cooperation to address and counter the world drug problem A/RES/71/211 51. Also encourages Member States to establish and strengthen partnerships and information exchange with industries, in particular with chemical and pharmaceutical industries and other relevant private sector entities, and encourage the use of the Guidelines for a Voluntary Code of Practice for the Chemical Industry, issued by the International Narcotics Control Board, and the Board’s model memorandum of understanding between Governments and private sector partners, as and where appropriate, bearing in mind the important role these industries can play in addressing and countering the world drug problem; 52. Calls upon Member States to commit to implementing timely, scientific evidence-based control or regulatory measures within national legislative and administrative systems to tackle and manage the challenge of new psychoactive substances, and to consider the use of interim steps while substances are under review, such as provisional measures of control, or to make public health announcements, as well as share information and expertise on those measures; 53. Invites Member States to support existing research, collection and scientific analysis of data related to amphetamine -type stimulants through the global Synthetics Monitoring: Analysis, Reporting and Trends (SMART) programme and relevant International Narcotics Control Board tools, such as Project Prism, and strengthen cooperation at all levels in tackling amphetamine -type stimulants, including methamphetamine; 54. Also invites Member States to promote the use, as appropriate, of relevant existing programmes, mechanisms and coordinated operations at all levels and continue the development and sharing of best practices and lessons learned among practitioners with regard to a balanced and integrated approach to the evolving threat of amphetamine-type stimulants; 55. Calls upon Member States to continue efforts to identify and monitor trends in the composition, production, prevalence and distribution of new psychoactive substances, as well as patterns of use and adverse consequences, and assess the risks to the health and safety of individuals and society as a whole and the potential uses of new psychoactive substances for medical and scientific purposes, and on that basis to develop and strengthen domestic and national legislative, regulatory, administrative and operational responses and practices by domestic and national legislative, law enforcement, judiciary, social and welfare, educational and health authorities; 56. Invites Member States to target the illicit cultivation of crops used for the illicit production and manufacture of drugs and address related factors by implementing comprehensive strategies aimed at alleviating poverty and strengthening the rule of law, accountable, effective and inclusive institutions and public services and institutional frameworks, as appropriate, and by promoting sustainable development aimed at enhancing the welfare of the affected and vulnerable population through licit alternatives; 57. Encourages the promotion of inclusive economic growth and support for initiatives that contribute to poverty eradication and the sustainability of social and economic development, and encourages Member States to develop measures for rural development, improving infrastructure and social inclusion and protection, addressing the consequences of illicit crop cultivation and the manufacture and production of narcotic drugs and psychotropic substances on the environment, with the incorporation and participation of local communities, and to consider taking voluntary measures to promote products stemming from alternative development, including preventive alternative development, as appropriate, to gain access to 13/20